Hikma

Hikma is an England-based multinational pharmaceutical firm that manufactures and distributes generic and in-licensed pharmaceutical products for healthcare organizations.

Business Model:

Revenue: $2.6B

Employees: 5,001-10,000

Rankings

Detailed Hikma Information

Geographic Data

Hikma headquarters map

Address: 1 New Burlington Place

City: London

State: england

Zip: W1S 2HR

Country: GB

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

323,635Website Global Rank

128,990Website Monthly Traffic

Twitter Followers

Description

Hikma is an England-based multinational pharmaceutical firm that manufactures and distributes generic and in-licensed pharmaceutical products for healthcare organizations.

Contact Phone:

Contact Email:

Hikma went public on 11/11/2005 on the London Stock Exchange

Listed Exchange:
London Stock Exchange

IPO Date:
11/11/2005

Ticker Symbol:
HIK

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
4/2011 Unimark Remedies Funding Round 33.3M
4/2011 Unimark Remedies Funding Round 0
Announced Date Transaction Number of Investors Money Raised Lead Investors

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research